The PMS, Perinatal, & Postpartum
Research Program

An Online Guide to the latest research in Women's Health


Publications

Yonkers KA, Kando JC, Cole JO, Blumenthal S: Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. American Journal of Psychiatry 149(5): 587-595, 1992.

Yonkers KA, White K: Premenstrual exacerbation of depression: One process or two? J Clin Psychiatry  53(8): 289-292, 1992.

Yonkers KA, Ellison J, Shera D, Pratt LA, Cole JO, Fierman E, Keller MB, Lavori PW: Description of anti- panic therapy in a prospective longitudinal study. J Clin Psychopharmacology 16:223-232, 1996.

Yonkers KA, Warshaw MG, Massion AO, Keller MB: Phenomenology and course of generalised anxiety disorder. British Journal of Psychiatry 168(3): 308-313, 1996.

Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ: Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacology 16(1): 3-8, 1996.

Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, Parry B, Pearlstein T, Severino S, Stout A, Stone A, Harrison W: Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 278(12): 983-988, 1997.

Yonkers KA, Zlotnick C, Allsworth J, Warshaw M, Shea T, Keller MB: Is the course of panic disorder the same in women and men?  American Journal of Psychiatry 155(5): 596-602, 1998. 

Yonkers KA,, Dyck I, Warshaw M, Keller MB: Factors predicting the clinical course of generalized anxiety disorder. British Journal of Psychiatry 176: 544-549, 2000.

Yonkers KA,, Dyck IR, Keller MB: An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women. Psych Services 52(5): 637-643, 2001.

Yonkers KA,, Ramin SM, Rush AJ, Navarrete CA, Carmody T, March D, Heartwell SF, Leveno KJ: Onset and persistence of postpartum depression . American Journal of Psychiatry 158(11): 1856-1863, 2001.

Yonkers KA,, Bruce SE, Dyck IR, Keller MB: Chronicity, relapse and illness-course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. J Affective Disorders 17(3): 173-179, 2003.

Yonkers KA,, Pearlstein T, Rosenheck RA: Premenstrual disorders: Bridging research and clinical reality. Archives of Women’s Mental Health 6(4): 287-292, 2003.

Yonkers KA,, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L: Management of bipolar disorder during pregnancy and the postpartum period. American Journal of Psychiatry 161(4): 608-620, 2004.

Smith MV, Rosenheck RA, Cavaleri MA, Howell HB, Poschman K, Yonkers KA,:  Screening for and detection of depression, panic disorder & PTSD in public-sector obstetric clinics. Psych. Services 55: 407-414, 2004.

Perkonigg A, Yonkers KA,, Pfister H, Lieb R, Wittchen H-U. Risk factors for premenstrual dysphoric disorder in a community sample of young women: The role of traumatic events and posttraumatic stress disorder. The J Clin Psychiatry, 2004; 65 (10): 1314-1322.

Yonkers KA,, Pearlstein T, Fayyad R, Gillespie JA. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. J Affective Disorders 85(3): 317-321, 2005.

Pearlstein T, Yonkers KA,, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affective Disorders 85: 275-282, 2005.

Bruce SE, Yonkers KA,, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study, American Journal of Psychiatry, 2005;162 (6):1179-87.

Yonkers KA,, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder. Obstetrics & Gynecology, 2005 106: 492-501.

Pearlstein T, Bachmann G, Zacur H, Yonkers KA,.  Treatment of premenstrual dysphoric disorder with a new drosperinone OC formulation.  Contraception, 2005; 73: 414- 421.

Yonkers KA, Holthausen GA, Poschman K, Howell HB.  Symptom onset treatment for women with premenstrual dysphoric disorder. J Clin Psychopharmacology. 2006, 26:198-202.

Smith MV, Poschman, KP, Allen AA, Cavaleri MA, Howell HB, Yonkers KA. Symptom Profiles of PTSD in Pregnancy. American Journal of Psychiatry, 2006, 163, pp 881-884.

Dean BB, Borenstein JE, Knight K and Yonkers KA:  Evaluating the Criteria Used for the Identification of PMS, J Women’s Health, 2006, 15 (5):546-555.

 

Halbreich U, Backstrom T, Eriksson E, O'Brien S, Calil H, Ceskova E, Dennerstein L, Douki S, Freeman E, Genazzani A, Heuser I, Kadri N, Rapkin A, Steiner M, Wittchen HU. Yonkers KA. Clinical diagnostic criteria for premenstrual syndrome and guidelines research studies. Gynecol Endocrinology, 2007, 23 (3):123-130.

 

Borenstein JE, Dean BB, Yonkers KA, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstetrics & Gynecology, 2007, 109 (5):1068-75.

Rogal SS, Poschman K, Belanger K, Howell HB, Smith MV, Medina J, Yonkers KA. Effects of posttraumatic stress disorder on pregnancy outcomes. Journal of Affective Disorders 2007;102:137-43

 

Recent Editorials, Reviews, Chapters, Books

  1.  Steiner M, Yonkers KA, Eriksson E (eds): Mood Disorders in Women, London, Martin Dunitz Ltd., 2000.

  2. Yonkers KA, Little B (eds): The Management of Psychiatric Illness in Pregnancy, Chapman Hall Ltd., 2000.

  3.  Yonkers KA, Davis LL:  Premenstrual Dysphoric Disorder. In Comprehensive Textbook of Psychiatry, Seventh Edition, Lippincott Williams & Wilkins, Vol II, pp.1952-1958, 2000.

  4.  Howell H, Brawman-Mintzer O, Monnier J, Yonkers KA: Generalized Anxiety Disorder in Women, The Psychiatric Clinics of North America, Vol 24, pp.165-178, 2001.

  5.  March D, Pearlstein T, Yonkers KA:  Treatment of Premenstrual Dysphoric Disorder, Psychiatric Clinics of North America: Annual of Drug Therapy, Vol 8, pp. 89-108, 2001.

  6. Yonkers KA, Kidner CL: Sex Differences in Anxiety Disorders In Psychiatric Illness in Women. Edited by Lewis-Hall F, Williams T, Panetta J, Herrera J. Washington, D.C., American Psychiatric Publishing, 2002, pp 5-30.

  7.  Shim J, Yonkers KA: Sertraline. In Textbook of Psychopharmacology. Edited by Schatzberg A, Nemeroff C. Washington, D.C., American Psychiatric Press, 2004, pp247-258.

  8.  Yonkers KA, Brawman-Mintzer O: Women. In Handbook of Experimental Pharmacology: Antidepressants: Past, Present and Future, Volume 157, Chapter 13, 2004, pp 379-392.


 

 

The PMS, Perinatal, & Postpartum Research Program
142 Temple Street, Suite 301
New Haven, CT 06510
Phone: (203) 764-6621
Toll-Free: (866) 600-6663
Fax: (203) 764-6766

women@yale.edu